Neostig (Neostigmine Methylsulfate)

Neostigmine Methylsulfate, the active ingredient in Neostig, is a cholinesterase inhibitor presented as a sterile injectable solution for intramuscular, intravenous, or subcutaneous use. It is employed to reverse non‑depolarizing neuromuscular blockade, manage myasthenia gravis, and treat postoperative ileus in adult patients.

GNH USA supplies Neostig as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global healthcare providers. All shipments are accompanied by full regulatory documentation and temperature‑controlled packaging where required.

Neostig acts on the cholinergic neuromuscular pathway and is used in several clinical situations.

Myasthenia gravis: improves muscle strength by increasing acetylcholine at the neuromuscular junction. Reversal of non‑depolarizing neuromuscular blockade: restores spontaneous breathing after anesthesia. Post‑operative ileus: stimulates gastrointestinal motility to reduce recovery time.

Neostig may produce a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Increased salivation - Bradycardia

Serious or Rare Side Effects: - Bronchospasm - Cholinergic crisis - Severe hypotension

Neostig requires careful clinical monitoring to minimise risk. - Renal impairment: adjust dose based on renal function. - Cardiac monitoring: observe for bradycardia and arrhythmias. - Asthma or COPD: use cautiously due to risk of bronchospasm. - Concomitant anticholinergics: may reduce efficacy, adjust therapy as needed. - Hypersensitivity: discontinue if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Neostig can interact with several drug classes, influencing safety and efficacy.

Major Interactions (Avoid): - Other cholinesterase inhibitors: risk of cholinergic overload. - Beta‑blockers: may exacerbate bradycardia. - Succinylcholine: can prolong neuromuscular effects.

Moderate Interactions (Monitor Closely): - Anticholinergic agents (e.g., atropine): may diminish therapeutic effect. - Anesthetic agents that depress cardiac function: require careful hemodynamic monitoring. - Diuretics: may potentiate hypotensive response.